Stock listing

OTC:MNZO Manzo Pharmaceuticals, Inc. Stock

Follow Manzo Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · OTC:MNZO

$0.0001 USD +0.0001

Close on Oct 14, 2026

Ticker: OTC:MNZO
Asset type: Stock
Exchange: OTC
Currency: USD

Latest news

Shareholder Meeting

Feb 24, 2022

Virtual Special Meeting

Feb 22, 2022

SEC Suspension of Trading

Mar 9, 2018

New Manzo Pharmaceuticals, Inc. Website

Oct 31, 2016

Manzo Pharmaceuticals, Inc announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.

Jul 29, 2016

Manzo Pharmaceuticals solidifies deal with USA based manufacturers to begin producing the company's lactose intolerance probiotic, Lacto-Freedom

Mar 24, 2016

Manzo Pharmaceuticals Gets Remarkable Results On Human Study Of Lacto-Freedom™ For Lactose Intolerance As The Company Prepares For Production

Feb 16, 2016

Manzo Pharmaceuticals starts human laboratory testing of the company's lactose intolerance probiotic, Lacto-Freedom™

Oct 15, 2015

Manzo Pharmaceuticals announces exciting new product release as the company prepares for the full-scale human study of its Lacto-Freedom product to begin

Jun 8, 2015

Manzo Pharmaceuticals Announces Plans for Human Clinical Studies of the Company's Patented Lactose Intolerance Probiotic, Lacto-Freedom™

Mar 11, 2015

All Manzo Pharmaceuticals, Inc. news

Manzo Pharmaceuticals, Inc. on 6ix

News releases: 20 in all · newest Feb 24, 2022 · oldest 2014

Log in to ask 6ix AI your own questions about Manzo Pharmaceuticals, Inc.